Have you ever wondered how we make crucial decisions in the early phases of clinical trials?
How can a Bayesian framework enhance these decisions?
Today, I talk with Audrey Yeo from Roche to answer these questions. Fresh from the PSI conference, Audrey, a seasoned statistical software engineer, introduces us to an innovative R package designed for early-phase clinical trials.
This tool promises to revolutionize decision-making with its Bayesian approach.
Join us as we explore the development, features, and impact of this groundbreaking tool, and discover the collaborative efforts that drive its evolution.
